See You Tonight at “Biotech’s Back in Seattle”

Xconomy Seattle — 

I’m getting ready for one of Xconomy’s biggest events of the year—“Biotech’s Back in Seattle“—which will be held tonight at PATH’s new headquarters in South Lake Union. More than 200 people have snapped up tickets so far, and only six seats are left at the time I’m writing this. So if you missed the last announcement before Thanksgiving, this is your last chance to register.

Tonight’s event will bring together some of the leaders in the Seattle biotech community for a conversation about what can be done to sustain some of the region’s newfound momentum. Dendreon’s Mitch Gold, Seattle Genetics’ Clay Siegall, Calistoga Pharmaceuticals’ Carol Gallagher, and Alder Biopharmaceuticals Randy Schatzman will be part of a feature panel in which they will take questions both from me and from you in the audience.

This is the second year in a row that Xconomy has scheduled an event right after the Thanksgiving break, and it reminds me of how thankful I am for all the support this community has given my colleagues and me as we pursue our dream in online journalism and community building. So special thanks tonight go out to PATH as the event host; as well as our event sponsors: Christensen O’Connor Johnson & Kindness, Cooley, Fenwick & West, and Wells Fargo Insurance Services.

Xconomy Seattle also has a fast-growing roster of 14 underwriters at last count who provide long-term support for our journalism and events like this one tonight. The group includes Alexandria Real Estate Equities, AMRI, Christensen O’Connor Johnson & Kindness, Cooley, Davis Wright Tremaine, Fenwick & West, the Institute for Systems Biology, Invest Northern Ireland, J. Robert Scott Executive Search, the Kauffman Foundation, the Science and Technology Directorate of the U.S. Department of Homeland Security, Seed IP, Swedish Medical Center, and Wells Fargo Insurance Services. We also have long-term support from three venture members—Arch Venture Partners, Vulcan Capital, and WRF Capital.

Of course, I can’t forget to thank our loyal and growing audience of readers for all your support and encouragement. See you there tonight.

By posting a comment, you agree to our terms and conditions.

3 responses to “See You Tonight at “Biotech’s Back in Seattle””

  1. JW says:

    Trust the event will be a success!

    Will you write a followup article about what happens at the event concerning DNDN?


  2. JW–thanks very much. yes, we’ll have a professional photographer there, and my trusty digital recorder rolling during the event. I’ve learned that it’s kind of hard to emcee, moderate, tweet, and take notes all at once, so it might take until tomorrow afternoon for me to post a recap here at Xconomy Seattle. But if Mitch Gold or Clay Siegall breaks any material news for shareholders (which I don’t expect) then I will definitely burn some midnight oil.


  3. jw says:


    Make it great!